(Q35571238)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585260%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

review article

1 reference

title

Prevention of chemotherapy and radiation toxicity with glutamine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585260%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585260%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Diane M F Savarese

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585260%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Gayle Savy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585260%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Paul E Wischmeyer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585260%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Barbara Corey

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585260%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 December 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585260%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

published in

Cancer Treatment Reviews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585260%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585260%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585260%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

501-513

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585260%20AND%20SRC:MED&resulttype=core&format=json

Intracellular free amino acid concentration in human muscle tissue

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Is glutamine a conditionally essential amino acid?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Effect of glutamine on tumor and host growth

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Glutamine-enriched diets support muscle glutamine metabolism without stimulating tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Glutamine and the preservation of gut integrity.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Dietary L-glutamine supplementation reduces the growth of the Morris Hepatoma 7777 in exercise-trained and sedentary rats

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Glutamine metabolism in lymphocytes of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Glutamine metabolism by the intestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Prophylactic glutamine protects the intestinal mucosa from radiation injury

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Gut-liver interaction during accelerated gluconeogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Plasma-amino acid profiles in sepsis and stress

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Glutamine enhances gut glutathione production

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Ammonia production and glutamine incorporation into glutathione in the functioning rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

The role of glutathione in determining the response of normal and tumor cells to anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Glutamine preserves liver glutathione after lethal hepatic injury

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Glutamine enhances selectivity of chemotherapy through changes in glutathione metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Effect of supplemental dietary glutamine on methotrexate concentrations in tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Mitochondrial glutathione depletion by glutamine in growing tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Safety and metabolic effects of L-glutamine administration in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Role of glutamine in bacterial transcytosis and epithelial cell injury

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Glutamine reduces phorbol-12,13-dibutyrate-induced macromolecular hyperpermeability in HT-29Cl.19A intestinal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

1 reference

7 January 2021

Claude H. Organ, Jr. Honorary Lectureship. Glutamine, cancer, and its therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Reduction of tumor growth following treatment with a glutamine antimetabolite

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Tumor regulation of hepatic glutamine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Harry M. Vars Research Award. Glutamine enhances immunoregulation of tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Effects of glutamine on head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Effect of dietary glutamate on chemotherapy-induced immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Glutamine requirements in the generation of lymphokine-activated killer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Glutamine suppresses PGE2 synthesis and breast cancer growth

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Immunostimulating effect of oral glutamine

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Intestinal permeability: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

l-glutamine stimulates jejunal sodium and chloride absorption in pig rotavirus enteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Glutamine and heat shock protein expression

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Glutamine induces heat shock protein and protects against endotoxin shock in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Pathologic changes secondary to radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Abdominal radiation causes bacterial translocation.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Prevention of chronic radiation enteropathy by dietary glutamine

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Oral glutamine reduces bacterial translocation following abdominal radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Phase III Double-Blind Study of Glutamine Versus Placebo for the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Oral glutamine to alleviate radiation-induced oral mucositis: a pilot randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

A review of the effects of glutamine-enriched diets on experimentally induced enterocolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Effect of a glutamine-supplemented enteral diet on methotrexate-induced enterocolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Effect of glutamine on methotrexate efficacy and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Inhibition of fluorouracil-induced stomatitis by oral cryotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Control of chemotherapy-induced diarrhea with octreotide. A randomized trial with placebo in patients receiving cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study)

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Reduction of chemotherapy-induced side-effects by parenteral glutamine supplementation in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

5-fluorouracil and folinic acid-induced mucositis: no effect of oral glutamine supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Cyclophosphamide priming reduces intestinal damage in man following high dose melphalan chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Oral glutamine in the prevention of chemotherapy-induced gastrointestinal toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Glutamine supplementation in cancer patients receiving chemotherapy: a double-blind randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Phase II trial of irinotecan in patients with metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Irinotecan (CPT-11) high-dose escalation using intensive high-dose loperamide to control diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Irinotecan is an active agent in untreated patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Glutamine for irinotecan diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Effect of thalidomide on gastrointestinal toxic effects of irinotecan

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Oral glutamine for the prevention of oral mucositis associated with high-dose paclitaxel and melphalan for autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Effect of oral glutamine supplementation during bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Parenteral glutamine protects hepatic function during bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Oral and parenteral glutamine in bone marrow transplantation: a randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Promotion of microtubule assembly in vitro by taxol

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Taxol: mechanisms of action and resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Axonal transport: components, mechanisms, and specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Cell attachment and neurite stability in NG108-15 cells: what is the role of microtubules?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Motor neuropathy due to docetaxel and paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Managing the neurotoxicity of paclitaxel (Taxol) and docetaxel (Taxotere) with neurotrophic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Amelioration of experimental cisplatin and paclitaxel neuropathy with glutamate

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Glutamine treatment of paclitaxel-induced myalgias and arthralgias

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Nerve growth factor prevents toxic neuropathy in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Mechanism of adriamycin cardiotoxicity: evidence for oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

The role of lipid peroxidation in acute doxorubicin-induced cardiotoxicity as studied in rat isolated heart

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Toxicity profile of dexrazoxane (zinecardR, icrf-187, adr-529, nsc-169780), a modulator of doxorubicin cardiotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Glutamine protects against doxorubicin-induced cardiotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Carnitine promotes heat shock protein synthesis in adriamycin-induced cardiomyopathy in a neonatal rat experimental model

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

Single dose of glutamine enhances myocardial tissue metabolism, glutathione content, and improves myocardial function after ischemia‐reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900133-6

7 January 2021

10.1016/S0305-7372(03)00133-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585260%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference